Matthew Gantz
Chief Executive Officer presso Castle Creek Biosciences, Inc.
Profilo
Matthew Gantz was the founder of Acureon Pharmaceuticals, Inc. (founded in 2006) and held the title of Chief Executive Officer.
He is currently the President, Chief Executive Officer & Director at Castle Creek Biosciences, Inc. (since 2021) and a Director at Marine Corps Scholarship Foundation.
Mr. Gantz previously served as the President & Chief Executive Officer at Hydra Biosciences, Inc., Chief Executive Officer at OxThera AB (from 2017 to 2021), Director at Life Sciences Pennsylvania, and Independent Director at Swedish Orphan Biovitrum AB.
He also held the position of Vice President-Europe & Biopharmaceutical Division at Chiron Corp.
(from 2000 to 2003) and General Manager-Europe at PathoGenesis Corp (from 1996 to 2000).
Additionally, Mr. Gantz was the President of PneumRx LLC and Executive Vice President at BTG Ltd.
(from 2009 to 2016) and BTG International, Inc. (from 2009 to 2016).
He also had roles as a Principal at United States Marine Corps and Abbott Laboratories Ltd.
Mr. Gantz completed his undergraduate degree at Princeton University and holds an MBA from Harvard Business School.
Posizioni attive di Matthew Gantz
| Società | Posizione | Inizio |
|---|---|---|
Marine Corps Scholarship Foundation
 Marine Corps Scholarship Foundation Investment Trusts/Mutual FundsMiscellaneous The Marine Corps Scholarship Foundation is a non-profit organization that provides financial assistance to Marines and their families for post-high school education, including undergraduate and career and technical education programs. The non-profit company is based in Alexandria, VA. The foundation aims to honor the service of Marines by helping to cover the cost of education. | Director/Board Member | - |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Chief Executive Officer | 20/04/2021 |
Precedenti posizioni note di Matthew Gantz
| Società | Posizione | Fine |
|---|---|---|
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Chief Executive Officer | 01/03/2021 |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | Chief Investment Officer | 01/06/2016 |
| BTG | Corporate Officer/Principal | 01/06/2016 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2003 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a private company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Corporate Officer/Principal | 01/01/2000 |
Formazione di Matthew Gantz
| Princeton University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Aziende private | 13 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a private company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
PneumRx LLC
 PneumRx LLC Medical SpecialtiesHealth Technology PneumRx, Inc. operates as a medical device company which focuses on developing minimally-invasive solutions for unmet medical needs in pulmonary medicine. Its product is a minimally invasive device intended to improve exercise capacity, lung function, and quality of life in patients with both heterogeneous and homogeneous emphysema. The company was founded by by Erin McGurk, Mark L. Mathis, and Ronald Dieck in 2004 and is headquartered in Mountain View, CA. | Health Technology |
Acureon Pharmaceuticals, Inc.
 Acureon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Acureon Pharmaceuticals, Inc. develops and markets therapeutics for infectious diseases. The firm’s synergistic combination of anti-infective expertise, dedicated clinical operations, marketing know-how and intellectual property, all coupled with well documented low attrition rates for anti-infective should translate into multiple product opportunities with a lower risk of failure, more rapid development timelines and early substantial returns on investment. The company was founded by Giorgio Mosconi in 2006 and is headquartered in Berwyn, PA. | Retail Trade |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | Finance |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Health Technology |
| United States Marine Corps | Government |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
Abbott Laboratories Ltd.
 Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The private company is based in Maidenhead, UK and was founded in 1937. | Health Technology |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
Marine Corps Scholarship Foundation
Marine Corps Scholarship Foundation Investment Trusts/Mutual FundsMiscellaneous The Marine Corps Scholarship Foundation is a non-profit organization that provides financial assistance to Marines and their families for post-high school education, including undergraduate and career and technical education programs. The non-profit company is based in Alexandria, VA. The foundation aims to honor the service of Marines by helping to cover the cost of education. | Miscellaneous |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
- Borsa valori
- Insiders
- Matthew Gantz
